Terms: = Uterine cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4
30 results:
1. Description of a Novel erbb4 -rearranged uterine Sarcoma.
Lim SH; Mansor SB; Kathirvel R; Kuick CH; Lim-Tan SK; McCluggage WG
Int J Gynecol Pathol; 2022 Sep; 41(5):508-513. PubMed ID: 34570017
[TBL] [Abstract] [Full Text] [Related]
2. Spitz nevus with a novel TFG-NTRK2 fusion: The first case report of NTRK2-rearranged Spitz/Reed nevus.
Goto K; Pissaloux D; Tirode F; de la Fouchardière A
J Cutan Pathol; 2021 Sep; 48(9):1193-1196. PubMed ID: 33979462
[TBL] [Abstract] [Full Text] [Related]
3. The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study.
da Costa LT; Dos Anjos LG; Kagohara LT; Torrezan GT; De Paula CAA; Baracat EC; Carraro DM; Carvalho KC
Clinics (Sao Paulo); 2021; 76():e2324. PubMed ID: 33503190
[TBL] [Abstract] [Full Text] [Related]
4. A pan-HER-targeted approach for recurrent or late-stage cervical cancer therapy: mechanisms, recent advances, and clinical prospects.
Liu Y; An Q; Zhao X
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4123-4131. PubMed ID: 32373948
[TBL] [Abstract] [Full Text] [Related]
5. Discrepancy in calculated and measured glomerular filtration rates in patients treated with PARP inhibitors.
Zibetti Dal Molin G; Westin SN; Msaouel P; Gomes LM; Dickens A; Coleman RL
Int J Gynecol Cancer; 2020 Jan; 30(1):89-93. PubMed ID: 31792084
[TBL] [Abstract] [Full Text] [Related]
6. Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study.
Xia C; Hu S; Xu X; Zhao X; Qiao Y; Broutet N; Canfell K; Hutubessy R; Zhao F
Lancet Public Health; 2019 Sep; 4(9):e462-e472. PubMed ID: 31493843
[TBL] [Abstract] [Full Text] [Related]
7. Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities.
Millis SZ; Jardim DL; Albacker L; Ross JS; Miller VA; Ali SM; Kurzrock R
Cancer; 2019 Apr; 125(7):1185-1199. PubMed ID: 30582752
[TBL] [Abstract] [Full Text] [Related]
8. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
[TBL] [Abstract] [Full Text] [Related]
9. Incidence of cervical high-grade squamous intraepithelial lesions in HIV-1-infected women with no history of cervical pathology: up to 17 years of follow-up.
Videla S; Tarrats A; Ornelas A; Badia R; Castella E; Alcalde C; Chamorro A; Esté JA; Clotet B; Sirera G
Int J STD AIDS; 2019 Jan; 30(1):56-63. PubMed ID: 30170532
[TBL] [Abstract] [Full Text] [Related]
10. Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing.
Cho SY; Choi M; Ban HJ; Lee CH; Park S; Kim H; Kim YS; Lee YS; Lee JY
Oncotarget; 2017 Jan; 8(5):8095-8104. PubMed ID: 28042953
[TBL] [Abstract] [Full Text] [Related]
11. [Endometrial cancer in young women--clinical and molecular aspects].
Lapińska-Szumczyk S; Supernat A; Żaczek AJ; Majewska H; Gulczyński J; Sawicki S; Biernat W; Wydra D
Ginekol Pol; 2014 Oct; 85(10):754-9. PubMed ID: 25546926
[TBL] [Abstract] [Full Text] [Related]
12. Genetic variations in EGFR and erbb4 increase susceptibility to cervical cancer.
Ma D; Hovey RL; Zhang Z; Fye S; Huettner PC; Borecki IB; Rader JS
Gynecol Oncol; 2013 Nov; 131(2):445-50. PubMed ID: 23927961
[TBL] [Abstract] [Full Text] [Related]
13. Expression and potential role of ErbB receptors in type II endometrial cancer.
Androutsopoulos G; Adonakis G; Liava A; Ravazoula P; Decavalas G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):204-8. PubMed ID: 23395558
[TBL] [Abstract] [Full Text] [Related]
14. [Rate of cervical intraepithelial neoplasia before HPV vaccination, Alpes-Maritimes 2006].
Bailly L; Bongain A; Mariné Barjoan E; Sattonnet C; Saos J; Durant ML; Mousteou F; Pradier C
Gynecol Obstet Fertil; 2011 Oct; 39(10):549-53. PubMed ID: 21856202
[TBL] [Abstract] [Full Text] [Related]
15. Gene expression profiling and cancer-related pathways in type I endometrial carcinoma.
Saghir FS; Rose IM; Dali AZ; Shamsuddin Z; Jamal AR; Mokhtar NM
Int J Gynecol Cancer; 2010 Jul; 20(5):724-31. PubMed ID: 20973258
[TBL] [Abstract] [Full Text] [Related]
16. Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer.
Mori N; Kyo S; Nakamura M; Hashimoto M; Maida Y; Mizumoto Y; Takakura M; Ohno S; Kiyono T; Inoue M
Br J Cancer; 2010 Sep; 103(6):889-98. PubMed ID: 20664599
[TBL] [Abstract] [Full Text] [Related]
17. Measurement of mRNA of 11 biomarkers by RT-PCR to detect lymph node involvement in cervical cancer.
Samouelian V; Revillion F; Alloy N; Lhotellier V; Leblanc E; Peyrat JP
Int J Biol Markers; 2008; 23(2):74-82. PubMed ID: 18629779
[TBL] [Abstract] [Full Text] [Related]
18. An integrated view of L-selectin and trophinin function in human embryo implantation.
Fukuda MN; Sugihara K
J Obstet Gynaecol Res; 2008 Apr; 34(2):129-36. PubMed ID: 18412772
[TBL] [Abstract] [Full Text] [Related]
19. The prognostic significance of human epidermal growth factor receptor correlations in squamous cell cervical carcinoma.
Fuchs I; Vorsteher N; Bühler H; Evers K; Sehouli J; Schaller G; Kümmel S
Anticancer Res; 2007; 27(2):959-63. PubMed ID: 17465227
[TBL] [Abstract] [Full Text] [Related]
20. Trophoblast cell activation by trophinin ligation is implicated in human embryo implantation.
Sugihara K; Sugiyama D; Byrne J; Wolf DP; Lowitz KP; Kobayashi Y; Kabir-Salmani M; Nadano D; Aoki D; Nozawa S; Nakayama J; Mustelin T; Ruoslahti E; Yamaguchi N; Fukuda MN
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3799-804. PubMed ID: 17360433
[TBL] [Abstract] [Full Text] [Related]
[Next]